The U.S. is in "big danger" of falling behind in vaccine technology research as government funding declines and vaccine ...

Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause ...

Moderna has tapped Swedish long-acting drug formulation company Nanexa to improve the delivery of up to five injectable ...

Specifically, the team tested whether mRNA technology could be used to protect against the damage inflicted by the venom of ...

No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating ...

The same technology used in COVID-19 vaccines could help prevent muscle damage from snakebites, according to a new study published in Trends in Biotechnology today [24 November]. The treatment reduced ...

COVID vaccine technology could help reduce disabilities in people caused by injuries from snakebites. Researchers at the University of Reading, England, found that the same mRNA tech used in ...

CDC data indicates that norovirus is back on the warpath and getting plenty of Americans sick.

Developers of mRNA therapeutics face an increasingly complex landscape: rising expectations for potency and durability, ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 6.4% in the afternoon session after a major long-term study from France indicated that its COVID-19 vaccine was safe and effective.

Prominent investor Ashish Kacholia has taken an equity position in TechInvention Lifecare Limited, a Mumbai-based ...